HIV Citation List: April 1 - April 14, 2009
Pubmed citations:
1. Discovery of Novel HIV Entry Inhibitors for the CXCR4 Receptor by Prospective Virtual Screening. Pérez-Nueno VI, Pettersson S, Ritchie DW, Borrell JI, Teixidó J. J Chem Inf Model. 2009 Apr 9. [Epub ahead of print]
PMID: 19358515
2. Enzymatic Glycosylation of Triazole-Linked GlcNAc/Glc-Peptides: Synthesis, Stability and Anti-HIV Activity of Triazole-Linked HIV-1 gp41 Glycopeptide C34 Analogues. Huang W, Groothuys S, Heredia A, Kuijpers BH, Rutjes FP, van Delft FL, Wang LX. Chembiochem. 2009 Apr 7. [Epub ahead of print]
PMID: 19353609
3. Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 13: synthesis of fluorine-containing diaryltriazine derivatives for in vitro anti-HIV evaluation against wild-type strain. Xiong YZ, Chen FE, Balzarini J, De Clercq E, Pannecouque C. Chem Biodivers. 2009 Apr;6(4):561-8.
PMID: 19353537
4. The Differential Binding and Activity of PRO 2000 Against Diverse HIV-1 Envelopes. Sachdev DD, Zerhouni-Layachi B, Ortigoza M, Profy AT, Tuen M, Hioe CE, Klotman ME. J Acquir Immune Defic Syndr. 2009 Apr 4. [Epub ahead of print]
PMID: 19349871
5. Water-Soluble Prodrugs of the Human Immunodeficiency Virus Protease Inhibitors Lopinavir and Ritonavir. Degoey DA, Grampovnik DJ, Flosi WJ, Marsh KC, Wang XC, Klein LL, McDaniel KF, Liu Y, Long MA, Kati WM, Molla A, Kempf DJ. J Med Chem. 2009 Apr 6. [Epub ahead of print]
PMID: 19348416
6. Synthesis and anti-HIV activity of conformationally restricted bicyclic hexahydroisobenzofuran nucleoside analogs. Díaz-Rodríguez A, Sanghvi YS, Fernández S, Schinazi RF, Theodorakis EA, Ferrero M, Gotor V. Org Biomol Chem. 2009 Apr 7;7(7):1415-23. Epub 2009 Feb 11.
PMID: 19300828
7. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.Lilienkampf A, Mao J, Wan B, Wang Y, Franzblau SG, Kozikowski AP. J Med Chem. 2009 Apr 9;52(7):2109-18.
PMID: 19271749
8. Synthesis and biological evaluation of N4-(hetero)arylsulfonylquinoxalinones as HIV-1 reverse transcriptase inhibitors. Xu B, Sun Y, Guo Y, Cao Y, Yu T. Bioorg Med Chem. 2009 Apr 1;17(7):2767-74. Epub 2009 Feb 25.
PMID: 19269831
9. Amide-containing diketoacids as HIV-1 integrase inhibitors: synthesis, structure-activity relationship analysis, and biological activity. Li H, Wang C, Sanchez T, Tan Y, Jiang C, Neamati N, Zhao G. Bioorg Med Chem. 2009 Apr 1;17(7):2913-9. Epub 2009 Feb 7.
PMID: 19269185
10. Modelling of cytotoxicity data (CC50) of anti-HIV 1-[5-chlorophenyl) sulfonyl]-1H-pyrrole derivatives using calculated molecular descriptors and Levenberg-Marquardt artificial neural network. Arab Chamjangali M. Chem Biol Drug Des. 2009 Apr;73(4):456-65.
PMID: 19291106
11. O-linked N-acetylglucosaminylation of Sp1 inhibits the human immunodeficiency virus type 1 promoter. Jochmann R, Thurau M, Jung S, Hofmann C, Naschberger E, Kremmer E, Harrer T, Miller M, Schaft N, Stürzl M. J Virol. 2009 Apr;83(8):3704-18. Epub 2009 Feb 4.
PMID: 19193796
12. Design and synthesis of novel dihydroquinoline-3-carboxylic acids as HIV-1 integrase inhibitors. Sechi M, Rizzi G, Bacchi A, Carcelli M, Rogolino D, Pala N, Sanchez TW, Taheri L, Dayam R, Neamati N. Bioorg Med Chem. 2009 Apr 1;17(7):2925-35. Epub 2008 Nov 6.
PMID: 19026554
13. Novel modifications in the series of O-(2-phthalimidoethyl)-N-substituted thiocarbamates and their ring-opened congeners as non-nucleoside HIV-1 reverse transcriptase inhibitors. Spallarossa A, Cesarini S, Ranise A, Bruno O, Schenone S, La Colla P, Collu G, Sanna G, Secci B, Loddo R. Eur J Med Chem. 2009 Apr;44(4):1650-63. Epub 2008 Sep 30.
PMID: 18954921
14. Isolation and characterization of a small antiretroviral molecule affecting HIV-1 capsid morphology. Abdurahman S, Vegvari A, Levi M, Hoglund S, Hogberg M, Tong W, Romero I, Balzarini J, Vahlne A. Retrovirology. 2009 Apr 8;6(1):34. [Epub ahead of print]
PMID: 19356241
15. Capsid (CA) Protein as a Novel Drug Target: Recent Progress in the Research of HIV-1 CA Inhibitors. Zhang J, Liu X, De Clercq E. Mini Rev Med Chem. 2009 Apr;9(4):510-8.
PMID: 19356128
16. First mariner mos1 transposase inhibitors. Bouchet N, Bischerour J, Germon S, Guillard J, Dubernet M, Viaud-Massuard MC, Delelis O, Ryabinin V, Bigot Y, Augé-Gouillou C. Mini Rev Med Chem. 2009 Apr;9(4):431-9.
PMID: 19356121
17. Anti-HIV evaluation of benzo[d]isothiazole hydrazones. Vicini P, Incerti M, La Colla P, Loddo R. Eur J Med Chem. 2009 Apr;44(4):1801-7. Epub 2008 Jul 9.
PMID: 18614259
18. Transport of lamivudine [(-)-beta-L-2',3'-dideoxy-3'-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3. Minuesa G, Volk C, Molina-Arcas M, Gorboulev V, Erkizia I, Arndt P, Clotet B, Pastor-Anglada M, Koepsell H, Martinez-Picado J. J Pharmacol Exp Ther. 2009 Apr;329(1):252-61. Epub 2009 Jan 13.
PMID: 19141712
ISI Web of Science citations:
19. In silico screening of oligosaccharide processing glycosidase inhibitor for HIV infection. Hakamata W, Takebe Y, Ushijima Y, Nishio T, Oku T. J PHARMACOL SCI, 2009; 109: 32P.
20. Binding Free Energy Calculations of Adenosine Deaminase Inhibitor and the Effect of Methyl Substitution in Inhibitors.Kosugi T, Nakanishi I, Kitaura K. J CHEM INF MODEL, 2009; 49(3): 615-22.
21. GERANYL DERIVATIVES OF SALSOLINOL SHOW INCREASED BIOLOGICAL ACTIVITIES SO HETEROCYCLES. Iwasa K, Okada S, Nishiyama Y, Takeuchi S, Moriyasu M, Tode C, Sugiura M, Takeuchi A, Tokuda H, Takeda K, Liu YN, Wu PC, Bastow KF, Akiyama T, Lee KH. HETEROCYCLES, 2009; 77(2): 1355-69.
22. Synergistic efficacy of combination of enfuvirtide and sifuvirtide, the first- and next-generation HIV-fusion inhibitors. Pan C, Lu H, Qi Z, Jiang SB. AIDS, 2009; 639-41.